filings.toolsItem 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER
3K characters. Original on sec.gov · Markdown
Item 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
The Company’s common stock trades on the NASDAQ Global Select Market under the symbol “TECH.” The following table sets forth for the periods indicated the high and low sales price per share for the Company’s common stock as reported by the NASDAQ Global Select Market.
| Fiscal 2011 Price | Fiscal 2010 Price | |||||||||||||||
| High | Low | High | Low | |||||||||||||
| 1st Quarter | $ | 63.44 | $ | 55.63 | $ | 65.54 | $ | 58.91 | ||||||||
| 2nd Quarter | 68.12 | 58.60 | 69.95 | 62.12 | ||||||||||||
| 3rd Quarter | 73.96 | 65.33 | 69.74 | 60.00 | ||||||||||||
| 4th Quarter | 83.82 | 71.54 | 67.65 | 57.10 |
As of August 24, 2011, there were over 28,000 beneficial shareholders of the Company’s common stock and over 190 shareholders of record. The Company paid quarterly cash dividends totaling $39.7 million and $38.4 million in fiscal 2011 and 2010, respectively. Its Board of Directors periodically considers the payment of cash dividends.
Table of Contents
The following chart compares the cumulative total shareholder return on the Company’s common stock with the S&P Midcap 400 Index and the S&P 400 Biotechnology Index. The comparison assumes $100 was invested on the last trading day before July 1, 2006 in the Company’s common stock and in each of the foregoing indices and assumes reinvestment of dividends.
The following table sets forth the repurchases of Company common stock for the quarter ended June 30, 2011.
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs | ||||||||||||
| 4/1/11 - 4/30/11 | 0 | 0 | 0 | $ | 50.6 million | |||||||||||
| 5/1/11 - 5/31/11 | 0 | 0 | 0 | $ | 50.6 million | |||||||||||
| 6/1/11 - 6/30/11 | 0 | 0 | 0 | $ | 50.6 million |
In November 2007, the Company authorized a plan for the repurchase and retirement of up to $150 million of its common stock. In April 2009, the Company authorized an additional $60 million for its stock repurchase plan. The plan does not have an expiration date.
Table of Contents
Previous: Item 4. (REMOVED AND RESERVED) · Next: Item 6. SELECTED FINANCIAL DATA